Fairfield, Bush & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Fairfield, Bush & Co's ABBV Position: Q3 2026 in Review
Fairfield, Bush & Co increased its AbbVie (ABBV) stake by 10% in Q3 2026, buying an estimated $186K and bringing the position to 7,755 shares worth $2.03M. The position accounts for 0.94% of the portfolio, ranked #33.
Fairfield, Bush & Co first reported a position in ABBV in Q1 2018 and has held it in 26 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Fairfield, Bush & Co held 7,755 shares of AbbVie worth $2.03M as of Q3 2026.
- Fairfield, Bush & Co bought 724 AbbVie shares in Q3 2026, an estimated $186K.
- AbbVie made up 0.94% of Fairfield, Bush & Co's portfolio in Q3 2026, its #33 holding.
- Fairfield, Bush & Co first reported a position in AbbVie in Q1 2018 and has held it in 26 quarters since.
- 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Fairfield, Bush & Co's 13F filing for Q3 2026, filed 13 Nov 2026.